12 November 2020
: Case report
Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease, Adverse events of drug therapy
Abdulrazaq S. Al-Jazairi1ABCDEF*, Haifa S. Alotaibi1ABCDEFDOI: 10.12659/AJCR.926951
Am J Case Rep 2020; 21:e926951
Table 2. Medications received by the patient during CS-ICU stay*.
Medications | Duration |
---|---|
Amiodarone intravenous continuous infusion for a total of 10 g as loading dose | Day 1–Day 12 |
Amiodarone 200 mg orally daily | Day 13–Day 17 |
Heparin intravenous continuous infusion (hospital ECMO protocol) | Day 1–Day 12 |
Nitroglycerin 200–150 mcg/min. intravenous continuous infusion | Day 1–Day 6 |
Hydralazine 10–20 mg intravenous q 6h | Day 1–Day 13 |
Nitroprusside 0.3–2 mcg/kg/min. intravenous continuous infusion | Day 2–Day 4 |
Amlodipine 10 mg orally daily | Day 2–Day 13 |
Metoprolol tartrate 12.5–50 mg orally twice daily | Day 3–Day 17 |
Captopril 25 mg orally 3 times daily | Day 5–Day 14 |
Vancomycin 1 g intravenous q 12h (adjusted according to patient’s renal function) | Day 2–Day 8 |
Ceftazidime 1 g intravenous q12h (adjusted according to patient’s renal function) | Day 2–Day 8 |
* CS-ICU=cardiac surgery intensive care unit, ** ECMO=extracorporeal membrane oxygenation support, *** hr=hour. |